Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma

Patients with advanced-stage Hodgkin lymphoma (HL) demonstrated excellent 2-year progression-free survival (PFS) after receiving positron emission tomography (PET)–adapted therapy on SWOG S0816. Patients received 2 cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD). Patients achie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Stephens, Deborah M., Li, Hongli, Schöder, Heiko, Straus, David J., Moskowitz, Craig H., LeBlanc, Michael, Rimsza, Lisa M., Bartlett, Nancy L., Evens, Andrew M., LaCasce, Ann S., Barr, Paul M., Knopp, Michael V., Hsi, Eric D., Leonard, John P., Kahl, Brad S., Smith, Sonali M., Friedberg, Jonathan W.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2019
Materias:
Lymphoid Neoplasia
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788007/
https://ncbi.nlm.nih.gov/pubmed/31331918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000719
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares